Abstract:Background We previously found that the structural defects of the coronary collateral microcirculation reserve (CCMR) prevent these preformed collateral vessels from continuously delivering the native collateral blood and supporting the ischemic myocardium in rats. Here, we tested whether these native collaterals can be remodeled by artificially increasing pigment epithelium–derived factor (PEDF) expression and demonstrated the mechanism for this stimulation. Methods and Results We performed intramyocardial gene delivery (PEDF‐lentivirus, 2×10 7 TU) along the left anterior descending coronary artery to artificially increase the expression of PEDF in the tissue of the region for 2 weeks. By blocking the left anterior descending coronary artery, we examined the effects of PEDF on native collateral blood flow and CCMR. The results of positron emission tomography perfusion imaging showed that PEDF increased the native collateral blood flow and significantly inhibited its decline during acute myocardial infarction. In addition, the number of CCMR vessels decreased and the size increased. Similar results were obtained from in vitro experiments. We tested whether PEDF induces CCMR remodeling in a fluid shear stress–like manner by detecting proteins and signaling pathways that are closely related to fluid shear stress. The nitric oxide pathway and the Notch‐1 pathway participated in the process of CCMR remodeling induced by PEDF. Conclusions PEDF treatment activates the nitric oxide pathway, and the Notch‐1 pathway enabled CCMR remodeling. Increasing the native collateral blood flow can promote the ventricular remodeling process and improve prognosis after acute myocardial infarction. Clinical Perspective What Is New? Pigment epithelium–derived factor induces increased organization of adherens junctions and diameter expansion of coronary collateral microcirculation reserve, which in turn improves collateral blood flow during acute myocardial infarction. We conclude that pigment epithelium–derived factor induces the remodeling of the coronary collateral microcirculation reserve in a manner similar to that of fluid shear stress. What Are the Clinical Implications? Our present findings demonstrate that promoting native collateral remodeling will effectively increase the compensatory blood flow and reduce the adverse effects of ischemic events, and they offer a practical approach for this promising novel therapeutic method for acute myocardial infarction. In the coronary vascular system, the coronary collateral circulation is critically important for the adaptation of the heart during ischemic events, because it mitigates ischemic injury and preserves cardiac function. 1 , 2 , 3 It is recognized that the presence of well‐functioning collaterals indicates that there will be less severe clinical manifestations of cardiac diseases and higher survival rates. 4 , 5 , 6 In acute coronary occlusion, the extent of native coronary collaterals, preformed in humans regardless of coronary artery disease, is a significant indication of the severity of myocardial infarction (MI). However, for the vast majority of the population, native collaterals only possess a limited ability to deliver compensatory blood flow. In the past few decades, researchers have fully realized that promoting the growth (angiogenesis) or structural remodeling of collateral vessels would theoretically increase the compensatory blood flow of ischemic myocardium. 7 , 8 , 9 Unfortunately, few studies in this area have shown tangible clinical value for patients with coronary artery disease. Coronary collateral growth is a process involving coordination between growth factors expressed in response to ischemia and mechanical forces. 10 Studies have demonstrated that vascular endothelial growth factor and angiotensin II can i -Abstract Truncated-

Pigment epithelium-derived factor attenuates myocardial fibrosis via inhibiting Endothelial-to-Mesenchymal Transition in rats with acute myocardial infarction

PEDF improves cardiac function in rats with acute myocardial infarction via inhibiting vascular permeability and cardiomyocyte apoptosis

Pigment epithelium-derived factor maintains tight junction stability after myocardial infarction in rats through inhibition of the Wnt/β-catenin signaling pathway

Pigment Epithelium-Derived Factor (PEDF) Improves Ischemic Cardiac Functional Reserve Through Decreasing Hypoxic Cardiomyocyte Contractility Through PEDF Receptor (PEDF-R)

Administration of pigment epithelium-derived factor inhibits left ventricular remodeling and improves cardiac function in rats with acute myocardial infarction

PEDF Inhibits VEGF-induced Vascular Leakage Through Binding to VEGFR2 in Acute Myocardial Infarction.

PEDF and 34-mer inhibit angiogenesis in the heart by inducing tip cells apoptosis via up-regulating PPAR-γ to increase surface FasL

PEDF improves cardiac function in rats subjected to myocardial ischemia/reperfusion injury by inhibiting ROS generation via PEDF‑R

PEDF and PEDF-derived peptide 44mer stimulate cardiac triglyceride degradation via ATGL

PEDF protects cardiomyocytes by promoting FUNDC1‑mediated mitophagy via PEDF-R under hypoxic condition

PEDF and 34‐mer peptide inhibit cardiac microvascular endothelial cell ferroptosis via Nrf2/HO‐1 signalling in myocardial ischemia‐reperfusion injury

Overexpressed pigment epithelium-derived factor alleviates pulmonary hypertension in two rat models induced by monocrotaline and SU5416/hypoxia

Pigment epithelium-derived factor plays an inhibitory role in proliferation and migration of HaCaT cells

Pigment Epithelium Derived Factor Inhibits the Growth of Human Endometrial Implants in Nude Mice and of Ovarian Endometriotic Stromal Cells in Vitro

Pigment Epithelium-Derived Factor Increases Native Collateral Blood Flow to Improve Cardiac Function and Induce Ventricular Remodeling After Acute Myocardial Infarction.

PEDF Inhibits the Activation of NLRP3 Inflammasome in Hypoxia Cardiomyocytes Through PEDF Receptor/Phospholipase A2.

Ethyl Ferulate suppresses Post-Myocardial Infarction Myocardial Fibrosis by Inhibiting Transforming Growth Factor Receptor 1

Dual Pigment Epithelium-derived Factor and Hepatocyte Growth Factor Overexpression: A New Therapy for Pulmonary Hypertension.

PEDF Improves Atherosclerotic Plaque Stability by Inhibiting Macrophage Inflammation Response.

Pharmacological Inhibition of Focal Adhesion Kinase Attenuates Cardiac Fibrosis in Mice Cardiac Fibroblast and Post-Myocardial-Infarction Models

PEDF is an endogenous inhibitor of VEGF-R2 angiogenesis signaling in endothelial cells